iTrace Pharmaceutical Solutions Private Limited

What iTrace Pharmaceutical Solutions Private Limited does

iTrace Pharmaceutical Solutions Private Limited is a privately held, India-based contract analytical chemistry laboratory founded in September 2020 and headquartered in Ambernath, Maharashtra. The company serves pharmaceutical companies with specialized testing services that support regulatory submissions to global regulated markets, including the United States. Its service portfolio spans seven core lines: extractables and leachables testing, nitrosamines analysis, method development and validation, glass delamination studies, elemental impurity analysis, genotoxic impurities testing, and medical device analysis per ISO 10993-17 and 18.

The underlying technical platform is built around advanced analytical instrumentation including LC-MS/MS, GC-MS/MS, ICP-MS, SEM-EDS, HPLC, FTIR, and UV spectrophotometry, with all methods aligned to USP, EMEA, PQRI, BPOG, and ISO guidelines. The company holds USFDA registration (FEI No. 3018238790), ISO 9001:2015 certification, National FDA site approval, and MSME registration, with NABL accreditation in process. The team is described as one of the most experienced in the Indian market for extractables-leachables, nitrosamines, and genotoxic impurities work.

The business operates on a project-based, quote-driven professional services model. Revenue is generated per testing engagement rather than via subscriptions or platform licensing, with multi-year contracts possible on larger programs. Go-to-market is direct sales-led through the company website, business development email, and phone-based contact with a small team of approximately 11 employees. The company is vertically focused on pharmaceutical clients and currently serves the South Asia market, with USFDA registration positioning it to support submissions into US-regulated markets.

Name

iTrace Pharmaceutical Solutions Private Limited

Legal name

i-Trace Pharmaceuticals Solutions Pvt. Ltd.

Website

https://itracepharma.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

iTrace Pharmaceutical Solutions is a USFDA-registered, ISO 9001:2015-certified contract analytical laboratory in Ambernath, India, providing specialized pharmaceutical testing services — including extractables and leachables, nitrosamines, genotoxic impurities, and glass delamination studies — to drug developers preparing global regulatory submissions.

Ownership category

akta.pro rank

Product category

Pharmaceutical Analytical Testing Services

NAICS

Testing Laboratories and Services (541380), Testing Laboratories and Services (54138)

SIC

Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Extractables & Leachables / Container-Closure Testing (HLAGADAI)

akta.pro secondary industries

Elemental Impurities & Trace Metals (ICP-MS) (HLAGADAJ), Method Development & Validation (ICH/USP) (HLAGADAB), Release Testing & Batch Certification (QC) (HLAGADAC), Impurity / Reference Standard Synthesis & Characterization (HLAGAHAG)

Keywords

• Pharmaceutical analytical testing
• Extractables leachables testing
• Nitrosamines impurity analysis
• Method development validation
• Regulatory compliance laboratory

Headquarters

HQ city

Ambernath

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Laboratory Testing Services: Analytical chemistry testing services including extractables/leachables, nitrosamines, method development/validation, glass delamination, elemental impurity analysis, and genotoxic impurities testing for pharmaceutical companies

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

iTrace Pharmaceutical Solutions operates an analytical chemistry testing laboratory serving pharmaceutical companies with specialized regulated studies. Its core offerings include extractables and leachables testing (per USP, PQRI, and BPOG), nitrosamines impurity analysis, method development and validation, glass delamination testing, elemental impurity analysis per USP 232/233, genotoxic impurity testing, medical device analysis per ISO 10993-17/18, and routine batch and stability testing. These services are delivered through advanced instrumentation (LC-MS/MS, GC-MS/MS, ICP-MS, SEM-EDS, HPLC, FTIR, UV) within a USFDA-registered, ISO 9001:2015-certified facility to support client submissions in regulated markets.

Product overview

iTrace Pharmaceutical Solutions Private Limited operates as an analytical testing laboratory providing a suite of specialized pharmaceutical testing services. The company's portfolio comprises seven distinct analytical service lines: Extractables and Leachable Testing (covering plastic, glass, and packaging analysis per USP, PQRI, and BPOG standards), Nitrosamines Testing, Method Development and Validation, Glass Delamination Testing, Elemental Impurity Analysis (per USP 232/233), Genotoxic Impurities Testing, and Medical Device Analysis (per ISO 10993-17 & 18). These services are supported by a range of analytical instrumentation including LC-MS/MS, GC-MS/MS, ICP-MS, SEM-EDS, HPLC, FTIR, and UV Spectrophotometry. The company functions as a single unified laboratory service rather than a modular software platform, delivering its services to pharmaceutical companies seeking regulatory compliance testing.

Differentiator

Problem solved

Functional benefit

Products and services

• Extractables and Leachable Testing Laboratory analysis of extractable and leachable compounds from pharmaceutical packaging and delivery systems, covering plastic, glass, and packaging analysis under USP, PQRI, and BPOG standards. Intended for pharmaceutical companies that must characterize packaging-related impurities to support regulatory submissions.
• Nitrosamines Testing Analysis and characterization of nitrosamine impurities in pharmaceutical products, addressing regulatory safety concerns and supporting product risk assessments and submissions.
• Method Development and Method Validation Custom analytical method development and validation services for pharmaceutical testing, supporting regulatory submissions, batch analysis, and stability studies.
• Glass Delamination Testing Laboratory analysis to detect and characterize glass delamination in pharmaceutical containers, ensuring container closure integrity and supporting container compatibility assessments.
• Elemental Impurity Analysis Determination of elemental impurities in pharmaceutical products as per USP 232 and 233 guidelines, ensuring compliance with safety thresholds and supporting regulatory submissions.
• Genotoxic Impurities Testing Identification and quantification of genotoxic impurities in pharmaceutical compounds to assess carcinogenic risk and ensure patient safety, supporting regulatory submissions.
• Medical Device Analysis Analytical testing of medical devices as per ISO 10993-17 and ISO 10993-18 standards, including toxicological assessment for medical device manufacturers.
• Routine Analysis and Batch Testing General pharmaceutical routine analysis and batch testing services supporting quality control across product lifecycle stages, including stability testing.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• WuXi AppTec: Global CRO/CDMO with comprehensive pharmaceutical testing services including extractables/leachables and nitrosamines. Comparable offerings but operates at vastly greater scale and global footprint.
• Intertek: Global quality assurance provider with pharmaceutical services spanning analytical testing, method development, and regulatory support. Overlaps with iTrace's pharma testing offering but at multi-national scale.
• SGS: Global inspection, verification, testing and certification company with a Life Sciences division offering pharmaceutical analytical services including impurity testing. Comparable buyer/use case but far larger and broader in scope.
• Eurofins Scientific: Global testing services giant with extensive pharmaceutical analytical testing capability including extractables/leachables, nitrosamines, and elemental impurities. iTrace competes for the same pharma testing wallet share but operates as a niche specialist against Eurofins' broad portfolio.

Direct peers

• Anthem Biosciences: Bangalore-based CRO/CDMO offering analytical services, formulation development, and impurity testing for pharma clients. Direct comparable in the Indian pharma analytical testing market.
• Pace Analytical Services: US-based analytical testing laboratory network serving pharmaceutical clients with method development, validation, and impurity testing. Comparable as a specialized analytical services provider for regulated industries.
• Syngene International: Bangalore-based CRO offering analytical method development, validation, and impurity testing for global pharma clients. Comparable as a direct competitor in pharmaceutical analytical services, though at significantly greater scale.
• Aragen Life Sciences (formerly GVK Biosciences): India-headquartered CRO offering analytical chemistry, method development, and impurity services for pharmaceutical clients. Directly comparable service portfolio in the Indian pharma testing market.
• Smithers: US-based specialist testing lab with strong extractables/leachables and pharmaceutical analytical services practice. Closest comparable in terms of niche specialization in E/L and packaging testing.
• Sai Life Sciences: India-headquartered CRO/CDMO providing analytical testing, method development, and impurity characterization services to pharmaceutical innovators and generics. Highly comparable service overlap in extractables/leachables and method validation.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

• Xx.com/itracepharma
• Facebookfacebook.com/sharer.php
• LinkedInlinkedin.com/company/itrace-pharmaceutical-solutions-private-limited

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about iTrace Pharmaceutical Solutions Private Limited